Dexamethasone Therapy for Low Back Pain

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02965196

Enrollment

Registered

2016-11-16

Start date

2016-12-31

Completion date

2017-03-31

Last updated

2016-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

The study will evaluate the efficacy of IV Dexamethasone in treatment low back pain as an adjunct to analgesics.

Interventions

DRUGIV Dexamethasone Therapy

OTHERIV Normal Saline (NaCl 0.9%)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* No red flags of serious spinal pathology * Normal neurological examination * Indication for opioid analgesia based on our pain management protocol * No known hypersensitivity to the medication * Ability to provide informed consent

Exclusion criteria

* Pregnancy * All others who do not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Pain Reduction	Four days	Pain will be measured according to the Visual Analog Scale throughout the treatment.

Countries

Israel

Contacts

Primary ContactItay Ophir, MD

ophir.itay@gmail.com972-543162177

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026